GRELARGO Trademark

Trademark Overview


On Monday, August 8, 2011, a trademark application was filed for GRELARGO with the United States Patent and Trademark Office. The USPTO has given the GRELARGO trademark a serial number of 85392214. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 6, 2015. This trademark is owned by Novartis AG. The GRELARGO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharma...
grelargo

General Information


Serial Number85392214
Word MarkGRELARGO
Filing DateMonday, August 8, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 6, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2012

Trademark Statements


Goods and ServicesAnti-infectives; Anti-inflammatories; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment and prevention of disorders of the metabolic system, the musculo-skeletal system, the genitourinary system and for the treatment of inflammatory disorders; pharmaceutical preparations for use in oncology and hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of gastroenterological disorders; Pharmaceutical products for ophthalmological use; Pharmaceutical products for treating respiratory diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 11, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, April 6, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, April 6, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 6, 2014EXTENSION 5 GRANTED
Friday, September 5, 2014EXTENSION 5 FILED
Friday, September 5, 2014TEAS EXTENSION RECEIVED
Saturday, March 8, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 7, 2014EXTENSION 4 GRANTED
Wednesday, March 5, 2014EXTENSION 4 FILED
Wednesday, March 5, 2014TEAS EXTENSION RECEIVED
Thursday, September 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2013EXTENSION 3 GRANTED
Thursday, September 5, 2013EXTENSION 3 FILED
Thursday, September 5, 2013TEAS EXTENSION RECEIVED
Friday, March 22, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 21, 2013EXTENSION 2 GRANTED
Tuesday, March 5, 2013EXTENSION 2 FILED
Wednesday, March 20, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 5, 2013TEAS EXTENSION RECEIVED
Tuesday, September 4, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 31, 2012EXTENSION 1 GRANTED
Friday, August 31, 2012EXTENSION 1 FILED
Friday, August 31, 2012TEAS EXTENSION RECEIVED
Tuesday, March 6, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, December 21, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 1, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2011ASSIGNED TO EXAMINER
Thursday, August 11, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 11, 2011NEW APPLICATION ENTERED IN TRAM